Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_assertion type Assertion NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_head.
- NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_assertion description "[However, the addition of ABT-737 to either a vaccine strategy involving priming with TRP-2 melanoma antigen peptide-pulsed DC and boosting with recombinant Listeria monocytogenes expressing the same melanoma antigen, or the adoptive transfer of TCR transgenic cells, did not result in superior antitumor activity against B16 murine melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_provenance.
- NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_assertion evidence source_evidence_literature NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_provenance.
- NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_assertion SIO_000772 18807035 NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_provenance.
- NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_assertion wasDerivedFrom befree-20140225 NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_provenance.
- NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_assertion wasGeneratedBy ECO_0000203 NP416868.RACW8y0q0Lul_po2v1lYApawU0qmRXt769VNuc9N-qg5Q130_provenance.